This column originally posted on RealMoney.com at 6:59 a.m. EDT. For more information about subscribing to RealMoney , please click here.The Biotech Mailbag is open. Our first email comes from Joe B., who asks for my thoughts on Panacos Pharmaceuticals (PANC).
Feuerstein's Biotech-Stock Mailbag: Panacos
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.